AngioDynamics (NASDAQ: ANGO) recently received a number of ratings updates from brokerages and research firms:7/17/2026 – AngioDynamics had its “sell (d-)” rating reaffirmed by Weiss Ratings. 7/16/2026 – AngioDynamics was downgraded by Zacks Research from “hold” to “strong sell”. 7/15/2026 – AngioDynamics had its price target raised by Canaccord Genuity Group Inc. from $16.00 to $20.00. 7/15/2026 – AngioDynamics had its price target raised by HC Wainwright from $16.00 to $19.00. See AlsoReceive News & Ratings for AngioDynamics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc and related companies with MarketBeat.com's FREE daily email newsletter.